1.
Dimopoulos MA, Kastritis E, Delimpassi S, Zomas A, Kyrtsonis MC, Zervas K. The International Prognostic Scoring System for Waldenström’s macroglobulinemia is applicable in patients treated with rituximab-based regimens. Haematologica [Internet]. 2008Aug.29 [cited 2026Nov.16];93(9):1420-2. Available from: https://haematologica.org/article/view/5012